GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lepu Biopharma Co Ltd (HKSE:02157) » Definitions » EPS (Diluted)

Lepu Biopharma Co (HKSE:02157) EPS (Diluted) : HK$-0.26 (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Lepu Biopharma Co EPS (Diluted)?

Lepu Biopharma Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$-0.13. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.26.

Lepu Biopharma Co's EPS (Basic) for the six months ended in Dec. 2024 was HK$-0.13. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.26.

Lepu Biopharma Co's EPS without NRI for the six months ended in Dec. 2024 was HK$-0.13. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.26.

During the past 3 years, the average EPS without NRIGrowth Rate was 30.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Lepu Biopharma Co's highest 3-Year average EPS without NRI Growth Rate was 30.20% per year. The lowest was -16.00% per year. And the median was 28.10% per year.


Lepu Biopharma Co EPS (Diluted) Historical Data

The historical data trend for Lepu Biopharma Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lepu Biopharma Co EPS (Diluted) Chart

Lepu Biopharma Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Diluted)
Get a 7-Day Free Trial -0.42 -0.75 -0.47 -0.01 -0.26

Lepu Biopharma Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.10 0.09 -0.13 -0.13

Competitive Comparison of Lepu Biopharma Co's EPS (Diluted)

For the Biotechnology subindustry, Lepu Biopharma Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lepu Biopharma Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lepu Biopharma Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Lepu Biopharma Co's PE Ratio falls into.


;
;

Lepu Biopharma Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Lepu Biopharma Co's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-439.215-0)/1690.482
=-0.26

Lepu Biopharma Co's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-233.763-0)/1710.835
=-0.14

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lepu Biopharma Co  (HKSE:02157) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lepu Biopharma Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Lepu Biopharma Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Lepu Biopharma Co Business Description

Traded in Other Exchanges
N/A
Address
No. 651, Lianheng Road, Minhang District, Shanghai, CHN, 201612
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.
Executives
Pu Zhongjie 2201 Interest of corporation controlled by you
Hu Chaohong 2201 Interest of corporation controlled by you
Pu Jue 2201 Interest of corporation controlled by you
Hao Chunmei 2202 Interest of your spouse
Su Rongyu 2101 Beneficial owner
Miracogen Inc. 2201 Interest of corporation controlled by you
Miracogen Limited 2101 Beneficial owner
Cereblue Limited 2201 Interest of corporation controlled by you
Bei Jing Hou De Yi Min Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Hou De Yi Min Xin Xi Ke Ji You Xian Gong Si 2101 Beneficial owner
Le Pu Bei Jing Yi Liao Qi Xie Gu Fen You Xian Gong Si 2101 Beneficial owner
Lv Yuan Shang Hai Ke Ji You Xian Gong Si 2101 Beneficial owner

Lepu Biopharma Co Headlines

No Headlines